Comparison of Extended Dose Letrozole Versus Letrozole Short Protocol for Ovulation Induction in Infertile Female with Polycystic Ovary Syndrome Receiving Metformin


PDF PDF

Keywords

Polycystic ovary syndrome
Infertility
Letrozole
Metformin
Ovulation induction
Follicular development
Endometrial thickness
Biochemical pregnancy.

How to Cite

1.
Comparison of Extended Dose Letrozole Versus Letrozole Short Protocol for Ovulation Induction in Infertile Female with Polycystic Ovary Syndrome Receiving Metformin. The Insight [Internet]. 2026 Nov. 15 [cited 2026 Nov. 17];9(03):905-9. Available from: https://bdjournals.org/insight/article/view/1655

Abstract

Background: Polycystic ovary syndrome (PCOS) is a leading cause of anovulatory infertility. Letrozole is widely used for ovulation induction, while metformin is recommended for insulin resistance in PCOS. However, comparative evidence on short- versus extended-course letrozole combined with metformin remains limited. Methods & Materials: This quasi-experimental study included 100 infertile women with PCOS at Dhaka Medical College Hospital, aged 18-35 years with BMI 25-29.9 kg/m². All received metformin (1500 mg/day) for 3 months, followed by either extended-course letrozole (2.5 mg twice daily, days 2-11) or short-course letrozole (5 mg twice daily, days 2-6). Follicular development was assessed by transvaginal sonography, with ovulation confirmed by mid-luteal serum progesterone (≥3 ng/mL). Outcomes included follicular response, endometrial thickness, ovulation, and biochemical pregnancy rates over three cycles. Results: The mean age was 25.9 ± 4.4 years, with BMI 25-29.9 kg/m², and baseline characteristics and hormone profiles were comparable between groups. After three cycles, Group A showed significantly higher mean follicle number (2.36 ± 1.03 vs. 1.87 ± 1.09; p = 0.024) and follicle size (18.05 ± 1.82 vs. 17.62 ± 1.91 mm; p = 0.041) in the third cycle. Overall, follicle number was also higher in Group A (1.87 ± 1.18 vs. 1.66 ± 1.16; p = 0.048), while differences in follicle size and endometrial thickness were not significant. Ovulation (82% vs. 71%) and cumulative biochemical pregnancy rates (24% vs. 18%) were higher in Group A, although not significantly. Side effects were minimal in both groups. Conclusion: Extended-course letrozole with metformin improved follicular development and ovulation compared with the short course, with a non-significant trend toward higher biochemical pregnancy rates.
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2026 The Insight